Research ArticleClinical Studies
Phase II Trial of Erlotinib plus Capecitabine as First-line Treatment for Metastatic Pancreatic Cancer (XELTA Study)
RAFAEL LÓPEZ, CARLOS MÉNDEZ MÉNDEZ, MÓNICA JORGE FERNÁNDEZ, CARLOS ROMERO REINOSO, GUILLERMO QUINTERO ALDANA, MERCEDES SALGADO FERNÁNDEZ, JUAN DE LA CÁMARA GÓMEZ, MARGARITA REBOREDO LÓPEZ, MANUEL RAMOS VÁZQUEZ and SONIA CANDAMIO FOLGAR
Anticancer Research February 2013, 33 (2) 717-723;
RAFAEL LÓPEZ
1University Hospital Complex of Santiago, Santiago de Compostela, Spain
CARLOS MÉNDEZ MÉNDEZ
2Oncology Center of Galicia, A Coruña, Spain
MÓNICA JORGE FERNÁNDEZ
3Xeral Cíes Hospital, Vigo, Spain
CARLOS ROMERO REINOSO
4Povisa Hospital, Vigo, Spain
GUILLERMO QUINTERO ALDANA
5University Hospital Lucus Augusti, Lugo, Spain
MERCEDES SALGADO FERNÁNDEZ
6Santa Maria Nai Hospital, Ourense, Spain
JUAN DE LA CÁMARA GÓMEZ
7Arquitecto Marcide Hospital, Ferrol, Spain
MARGARITA REBOREDO LÓPEZ
8University Hospital Center of A Coruña, A Coruña, Spain
MANUEL RAMOS VÁZQUEZ
2Oncology Center of Galicia, A Coruña, Spain
SONIA CANDAMIO FOLGAR
1University Hospital Complex of Santiago, Santiago de Compostela, Spain
In this issue
Anticancer Research
Vol. 33, Issue 2
February 2013
Phase II Trial of Erlotinib plus Capecitabine as First-line Treatment for Metastatic Pancreatic Cancer (XELTA Study)
RAFAEL LÓPEZ, CARLOS MÉNDEZ MÉNDEZ, MÓNICA JORGE FERNÁNDEZ, CARLOS ROMERO REINOSO, GUILLERMO QUINTERO ALDANA, MERCEDES SALGADO FERNÁNDEZ, JUAN DE LA CÁMARA GÓMEZ, MARGARITA REBOREDO LÓPEZ, MANUEL RAMOS VÁZQUEZ, SONIA CANDAMIO FOLGAR
Anticancer Research Feb 2013, 33 (2) 717-723;
Phase II Trial of Erlotinib plus Capecitabine as First-line Treatment for Metastatic Pancreatic Cancer (XELTA Study)
RAFAEL LÓPEZ, CARLOS MÉNDEZ MÉNDEZ, MÓNICA JORGE FERNÁNDEZ, CARLOS ROMERO REINOSO, GUILLERMO QUINTERO ALDANA, MERCEDES SALGADO FERNÁNDEZ, JUAN DE LA CÁMARA GÓMEZ, MARGARITA REBOREDO LÓPEZ, MANUEL RAMOS VÁZQUEZ, SONIA CANDAMIO FOLGAR
Anticancer Research Feb 2013, 33 (2) 717-723;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.